Hematopoietic/Lymphoid Cancer Terminated Phase 1 Trials for Decitabine (DB01262)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089089Decitabine in Treating Patients With Advanced Refractory Solid Tumors or LymphomasTreatment